- $514.30m
- $1.18bn
- $138.78m
- 40
- 59
- 51
- 48
Annual balance sheet for Global Medical REIT, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 5.51 | 7.21 | 4.02 | 1.28 | 6.82 |
Net Total Receivables | 5.7 | 6.23 | 8.24 | 6.96 | 7.69 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 979 | 1,116 | 1,198 | 1,122 | 1,116 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Other Assets | |||||
Total Assets | 1,101 | 1,263 | 1,393 | 1,268 | 1,256 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 656 | 641 | 760 | 684 | 722 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 445 | 623 | 633 | 584 | 534 |
Total Liabilities & Shareholders' Equity | 1,101 | 1,263 | 1,393 | 1,268 | 1,256 |
Total Common Shares Outstanding |